| 리툭시맙에 치료효과를 보인 만성염증탈수초다발신경병 |
|
김다영, 최교민, 오지영 |
|
건국대학교병원 신경과 |
| Successful Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Rituximab |
|
Dayoung Kim, Kyomin Choi, Jeeyoung Oh |
|
Department of Neurology, Konkuk University Medical Center, Seoul, Korea |
|
|
| Abstract |
|
"Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a heterogeneous autoimmune disease characterized by a relapsing and remitting or progressive pattern. Corticosteroid, intravenous immunoglobulin or plasma exchange are usually used as treatment options. However, approximately one-third of patients with CIDP have an inadequate response to standard treatments. Rituximab, a monoclonal antibody against CD20, has been used with good results in some patients with refractory CIDP. We report a patient with refractory CIDP in whom remission has been successfully maintained after treatment with rituximab. Journal of Multiple Sclerosis and Neuroimmunology 12(2):39-42, 2021" |
| Key Words:
Polyradiculoneuropathy, Chronic inflammatory demyelinatin, Rituximab |
|
PDF Links
Download Citation
